These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13352306)

  • 21. Use of chelating agents in treatment of metal poisoning (with special emphasis on lead).
    FOREMAN H
    Fed Proc; 1961 Sep; 20(3)Pt 2():191-6. PubMed ID: 13894041
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent developments in the care of workers exposed to lead; the effect of the calcium chelate of disodium ethylenediamine-tetraacetic acid on lead in the blood and urine of battery workers.
    MANVILLE IA; MOSER R
    AMA Arch Ind Health; 1955 Nov; 12(5):528-38. PubMed ID: 13268074
    [No Abstract]   [Full Text] [Related]  

  • 23. Penicillamine as lead-chelating substance in man.
    OHLSSON WT
    Br Med J; 1962 May; 1(5290):1454-6. PubMed ID: 14481385
    [No Abstract]   [Full Text] [Related]  

  • 24. [Unithiole therapy in lead poisoning].
    Anatovskaia VS
    Vrach Delo; 1965 Jun; 6():84-6. PubMed ID: 5856059
    [No Abstract]   [Full Text] [Related]  

  • 25. Lead excretion following oral dlpenicillamine with a method for comparing the relative effectiveness of chelating agents on the excretion of lead.
    MOSSER RS; BESSMAN SP
    Bull Sch Med Univ Md; 1960 Jul; 45():47-9. PubMed ID: 14424633
    [No Abstract]   [Full Text] [Related]  

  • 26. Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(8):204-7. PubMed ID: 16511441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood lead poisoning and its treatment.
    Angle CR
    Annu Rev Pharmacol Toxicol; 1993; 33():409-34. PubMed ID: 8494346
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic nephropathy in saturnism. Comparative elimination of lead by classic chelating agents and peritoneal dialysis].
    Mirouze J; Mion C; Mathieu-Daude P; Monnier L; Selam JL
    Nouv Presse Med; 1975 May; 4(22):1642-4. PubMed ID: 1215179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of the liposomal approach to metal chelation therapy.
    Rahman YE
    Front Biol; 1979; 48():625-52. PubMed ID: 227757
    [No Abstract]   [Full Text] [Related]  

  • 31. How to diagnose and treat lead poisoning in children.
    Browder A
    Med Times; 1972 Oct; 100(10):203-4 passim. PubMed ID: 5073971
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute lead arsenate poisoning.
    Geddes R
    Aust N Z J Med; 1990 Oct; 20(5):750-1. PubMed ID: 2126731
    [No Abstract]   [Full Text] [Related]  

  • 33. Chelation in contrast roentgenography with special reference to lead disodium edta.
    SHAPIRO R
    Am J Roentgenol Radium Ther Nucl Med; 1956 Jul; 76(1):161-7. PubMed ID: 13327146
    [No Abstract]   [Full Text] [Related]  

  • 34. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of extreme acute lead intoxication.
    Mikler J; Banovcin P; Jesenak M; Hamzikova J; Statelova D
    Toxicol Ind Health; 2009 Mar; 25(2):137-40. PubMed ID: 19458136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lead still poisoning our children.
    Yoder PE; Burright RG; Donovick P
    RN; 1993 Feb; 56(2):28-32. PubMed ID: 8438123
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent onset cases of lead poisoning among painters].
    Nakamura K; Kitahara T; Taoda K
    Sangyo Eiseigaku Zasshi; 2015; 57(5):241-3. PubMed ID: 26105568
    [No Abstract]   [Full Text] [Related]  

  • 38. Is modified citrus pectin an effective mobilizer of heavy metals in humans?
    Crinnion W
    Altern Med Rev; 2008 Dec; 13(4):283-6. PubMed ID: 19238763
    [No Abstract]   [Full Text] [Related]  

  • 39. What is the appropriate treatment regimen for a lead-exposed employee with a blood lead level of 60 micrograms/dl?
    J Occup Med; 1993 Sep; 35(9):885. PubMed ID: 8229336
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-treatment of screened children with intermediate blood lead levels.
    Klein MC; Schlageter M
    Pediatrics; 1975 Aug; 56(2):298-302. PubMed ID: 1161378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.